	UNITED STATES ENVIRONMENTAL PROTECTION AGENCY

	WASHINGTON, D.C.  20460

OFFICE OF PREVENTION, PESTICIDES AND TOXIC SUBSTANCES

April 10, 2007

MEMORANDUM

SUBJECT:	Review of Fenoxycarb Incident Reports

		DP Barcode D337388, Chemical #125301

FROM:	Monica Hawkins, M.P.H., Environmental Health Scientist

		Chemistry and Exposure Branch

		Health Effects Division (7509P)

		Hans Allender, Ph.D., Statistician

		Chemistry and Exposure Branch

		Health Effects Division (7509P)

THRU:	David J. Miller, Chief

		Chemistry and Exposure Branch

		Health Effects Division (7509P)

TO:		Katherine Hall, Chemical Review Manager

		Special Review and Reregistration Division (7508P)

BACKGROUND

To generate this review, the Office of Pesticides (OPP) consulted the
following databases for the poisoning incidents on the active ingredient
Fenoxycarb. The purpose of the database searches is to identify
potential patterns of the extent and severity of the health effects
attributed to Fenoxycarb exposure.

1)  Poison Control Centers – OPP purchases American Association of
Poison Control Center (AAPCC) data covering the years 1993 through 2005
for all reported pesticides incidents. The last acquisition of data
covering 2004 and 2005 took place in late 2006. Most of the national
Poison Control Centers (PCCs) participate in a national data collection
system, previously called The Toxic Exposure Surveillance System (TESS).
PCC reports includes 61 centers at hospital and universities that cover
100% of the United States population. Datasets incorporate an extensive
quality assurance process including a standardized computer-based data
collection. Some PCCs cover multiple States; others cover a metropolitan
area, or an entire State. PCCs provide telephone consultation for
individual consumers and health care providers on suspected poisonings,
involving drugs, household products, pesticides, etc.; data collection
to aid pesticide regulatory programs is secondary to this service. An
elaborate, computer assisted protocol is followed by specially trained
medical staff, and reports assess confirmed, possible, probable, or
definite pesticide exposures. Approximately 50% of base reports include
medical follow-up and clinical outcome are determined, e.g., cases
resolved by phone consultation with PCC specialist, patients seen in
health care facility, patients hospitalized, and patients admitted to
Intensive Care Unit (ICU) and in some cases death. PCCs receive calls 24
hours a day throughout the entire year, and they handle non-occupational
as well as occupational calls. Discussions are underway to improve
collection of OPP-specific occupational data. Because mainly consumers
initiate PCC calls, this database is not currently a complete source of
occupational poisoning incidents.

2)  OPP Incident Data System (IDS) This database includes reports of
incidents from various sources, including mandatory Federal Insecticide,
Fungicide and Rodenticide Act (FIFRA) Section 6 (a) (2) reports from
registrants, other federal and state health and environmental agencies
and individual consumers.  The IDS has been in existence since 1992.
Reports submitted to the Incident Data System represent anecdotal
reports or allegations only, unless otherwise stated in this report.
Typically, OPP does not draw conclusions implicating the pesticide as a
cause of any of the reported health effects.  Nevertheless, sometimes
with enough cases and/or documentation, patterns and risk mitigation
measures may be suggested.

3) National Institute of Occupational Safety and Health Sentinel Event
Notification System for Occupational Risks (NIOSH/SENSOR) performs
standardized surveillance in twelve states from 1998 through 2006.
States included in this reporting system are Arizona, California,
Florida, Iowa, Louisiana, Michigan, North Carolina, New York, New
Mexico, Oregon, Texas, and Washington. A number of other States can and
do report, periodically and on request for special circumstances,
because they participate in the NIOSH/ SENSOR network as part of the
Council of State and Territorial Epidemiologists (CSTE).  Reporting is
variable from state-to-state because of the dissimilar cooperation from
different sources of reporting (e.g., workers compensation, Poison
Control Centers, emergency departments and hospitals, enforcement
investigations, private physicians, etc.).  Therefore, OPP does not
characterize these reports as estimating the total magnitude of
poisoning for a State.  The focus of OSHA/SENSOR database is on
occupationally related cases. However, the information collected on each
case is standardized and categorized according to the certainty of the
information collected and the severity of the case. Detailed exposure
circumstances may be available if the State provided follow-up case
reports, as in serious cases ending in death.

The purpose of this review is to summarize available pesticide poisoning
incident data for the active ingredient Fenoxycarb. This report contains
3 sections:

1- Cases reported in the Poison Control Center Database from 1993 to
2005

2- Cases reported in the Incident Data System from 1999 to the present,
and

3- Cases reported in the NIOSH system from 1998 to 2003.

1.	  SEQ CHAPTER \h \r 1 Poison Control Center Data – 1993-2005

This section discusses results from the Poison Control Center’s Toxic
Exposure Surveillance System (TESS) from the years 1993 through 2005 and
reflects data stratified by population: occupational, non-occupational,
and children. The children class is five years of age or less; this
definition includes children about to become six years old, or up to 72
months old. Cases involving exposures to multiple products and cases
with unrelated medical outcome are excluded.  Also excluded are
intentional exposures, i.e., suicide attempts. The tables incorporated
in this section contain summaries of acute pesticide poisoning incidents
resulting from exposure to Fenoxycarb.

The following tables evaluate the frequency of poisoning incidents for
Fenoxycarb compared to the composite of all pesticides for which the PCC
received a non-excluded incident report.  The tables report the
frequency of events by health severity category (i.e.; all symptoms,
moderate, and major) and by level of health care received.  A
comparative ratio provides a simple measure of the relative frequency of
reported health effects by severity category.  Knowledge of the ratios
of symptoms for a single chemical (or a group of chemicals) provides a
relative measure of the public health impact of the acute pesticide
events.  In addition, a Likelihood Ratio test shows whether the compound
under study is significantly different from the average of all other
pesticides.  An (s) next to the ratio indicates the proportions are
significantly different.

For a detailed explanation of the tables, see Attachment 2.

Table 1. Relative Frequency of Acute Pesticide Poisoning Incidents by
Symptom Severity: Occupational Cases

	Severity of outcome

(outcome determined)	Total

exposed	Health care

provided

Denominator numbers	14	16	10

Measures	SYM1	MOD2	MAJ3	HCF4	HOSP5	ICU6

Numerator numbers	14	2	0	10	0	0

Fenoxycarb percents	100.00%	14.29%	0.00%	62.50%	0.00%	0.00%

Average of all Pesticides 	86.25%	20.89%	0.81%	42.94%	7.00%	2.83%

Ratio of  Fenoxycarb

to average of all pesticides	1.16

P =0.13	0.68

P = 0.54	0.00

P = 0.73	1.46

P = 0.11	0.00

P = 0.38	0.00

P =0.59

1) Percent of cases with ANY symptom in relation to the total of cases
followed; 2) Percent with moderate symptoms in relation to the total of
cases followed; 3) Percent with major or fatal outcome in relation to
the total of cases followed; 4) Percent of case seen in a Health Care
Facility (HCF) in relation to total exposures; 5) Percent of cases seen
in a Hospital in relation to cases seen in a HCF; 6) percent of cases
taken to an Intensive Care Unit (ICU) in relation to cases seen in a
HCF.

Table 2. Relative Frequency of Acute Pesticide Poisoning Incidents by
Symptom Severity: Non-Occupational Cases

	Severity of outcome

(outcome determined)	Total

exposed	Health care

provided

Denominator numbers	10	26	3

Measures	SYM1	MOD2	MAJ3	HCF4	HOSP5	ICU6

Numerator numbers	5	1	0	3	1	1

Fenoxycarb percents	50.00%	10.00%	0.00%	11.54%	33.33%	33.33%

All Pesticides percents	64.72%	10.61%	0.45%	15.45%	7.94%	3.02%

Ratio of  Fenoxycarb

to average of all pesticides	0.77

P =0.33	0.94

P = 0.95	0.00

P = 0.83	0.75

P = 0.57	4.20

P = 0.10	11.04 (S)

P =0.00 (*)

1) Percent of cases with ANY symptom in relation to the total of cases
followed; 2) Percent with moderate symptoms in relation to the total of
cases followed; 3) Percent with major or fatal outcome in relation to
the total of cases followed; 4) Percent of case seen in a Health Care
Facility (HCF) in relation to total exposures; 5) Percent of cases seen
in a Hospital in relation to cases seen in a HCF; 6) percent of cases
taken to an Intensive Care Unit (ICU) in relation to cases seen in a
HCF.

 (*) Sample size not big enough for a reliable test.

Table 3. Relative Frequency of Acute Pesticide Poisoning Incidents by
Symptom Severity: Children Cases

	Severity of outcome

(outcome determined)	Total

exposed	Health care

provided

Denominator numbers	21	35	5

Measures	SYM1	MOD2	MAJ3	HCF4	HOSP5	ICU6

Numerator numbers	3	0	0	5	0	0

Fenoxycarb percents	14.29%	0.00%	0.00%	14.29%	0.00%	0.00%

All Pesticides percents	23.16%	1.48%	0.13%	14.80%	4.48%	1.41%

Ratio of  Fenoxycarb

to average of all pesticides	0.62

P =0.34	0.00

P = 0.57	0.00

P = 0.86	0.97

P = 0.93	0.00

P = 0.62	0.00

P =0.78

1) Percent of cases with ANY symptom in relation to the total of cases
followed; 2) Percent with moderate symptoms in relation to the total of
cases followed; 3) Percent with major or fatal outcome in relation to
the total of cases followed; 4) Percent of case seen in a Health Care
Facility (HCF) in relation to total exposures; 5) Percent of cases seen
in a Hospital in relation to cases seen in a HCF; 6) percent of cases
taken to an Intensive Care Unit (ICU) in relation to cases seen in a
HCF.

Table 4. Relative Frequency of Acute Pesticide Poisoning Incidents by
Symptom Severity: Combination of All Cases Regardless Class

	Severity of outcome

(outcome determined)	Total

exposed	Health care

provided

Denominator numbers	45	77	18

Measures	SYM1	MOD2	MAJ3	HCF4	HOSP5	ICU6

Numerator numbers	22	3	0	18	1	1

Fenoxycarb percents	48.89%	6.67%	0.00%	23.38%	5.56%	5.56%

All Pesticides percents	42.69%	6.02%	0.29%	16.01%	6.05%	2.16%

Ratio of  Fenoxycarb

to average of all pesticides	1.15

P =0.40	1.11

P = 0.85	0.00

P = 0.71	1.46

P = 0.09	0.92

P = 0.93	2.57

P =0.32

1) Percent of cases with ANY symptom in relation to the total of cases
followed; 2) Percent with moderate symptoms in relation to the total of
cases followed; 3) Percent with major or fatal outcome in relation to
the total of cases followed; 4) Percent of case seen in a Health Care
Facility (HCF) in relation to total exposures; 5) Percent of cases seen
in a Hospital in relation to cases seen in a HCF; 6) percent of cases
taken to an Intensive Care Unit (ICU) in relation to cases seen in a
HCF.

Table 5 provides a summary by year, and Figure 1 shows a graphical
summary for annual exposure, symptomatic cases, and cases seen in a
health care facility.

Table 5. Summary of Cases by Year

Summary of Cases by Year

Year	Symptomatic

Cases	Moderate

Cases	Major

Cases	Cases

Followed	Total Exposed	HCF

Cases	Hospital

Cases	ICU

Cases

1993	4	2	0	6	13	3	1	1

1994	2	0	0	4	7	2	0	0

1995	8	0	0	15	21	5	0	0

1996	4	0	0	8	11	4	0	0

1997	1	0	0	4	8	2	0	0

1998	1	0	0	2	3	0	0	0

1999	2	1	0	5	8	2	0	0

2000	0	0	0	0	2	0	0	0

2001	0	0	0	0	1	0	0	0

2002	0	0	0	0	1	0	0	0

2003	0	0	0	0	0	0	0	0

2004	0	0	0	1	2	0	0	0

2005	0	0	0	0	0	0	0	0

Total	22	3	0	45	77	18	1	1

Figure 1 Total exposure, symptomatic cases, and cases sent to HCF by
year

Analysis of Results

For the occupational class, no percentage of Fenoxycarb is statistically
different from the percentages for the composite of all pesticides. The
table shows a small number of exposures cases; only 16 cases in the
period 93-05. Similar results are observed in the non-occupational
class. With 26 exposures reported in 13 years, the non-occupational
class shows low ratios; only one case produced moderate symptoms that
triggered health care activity. The results for Fenoxycarb on children
produced non-significant lower ratios in all columns.  For the entire
population, results are not significantly different from the composite
average of all pesticides.

A diminishing trend in total exposure, symptomatic cases, and cases seen
in a HCF is apparent for the 13 year-span of data collected on
Fenoxycarb with very few cases occurring since 2000. Calculations show
an average of about 5.9 exposures per year, 1.7 symptomatic cases per
year, and 1.4 cases per year seen in a heath care facility.

Based on PCC reports, exposure to Fenoxycarb produced health symptoms
concentrated in two main areas, and within each area, the symptoms were:

Gastro Intestinal: nausea, abdominal pain, and

Neurological: headache, and dizziness/vertigo

2. Cases reported in the Incident Data System from 1999 to the present

Seventeen cases were reported in the IDS. For a detailed description,
see Attachment 1.

3. NIOSH SENSOR

Out of 5,899 reported cases from 1998 to 2003, there is only one case
reported in the SENSOR database involving Fenoxycarb. A 31-year-old
woman reported symptoms in Texas. The symptoms were nausea, lacrimation
and dyspnea/shortness of breath with no medical treatment sought.

Study Summary

The summary findings for the period 1999 to 2003 for Fenoxycarb are:

Fenoxycarb does not produce any significant results in any of the
classes when compared to the composite of all pesticides.

Fenoxycarb data shows low averages results with about 5.9
exposures/year, 1.7 symptomatic cases/year, and 1.4 cases/year seen in a
heath care facility.

No apparent annual trend is noticed in the 13 year-span, however the
data shows very low incidents in the last six years.

Conclusions/ Recommendations

Based on the incident data reviewed from the above sources, OPP suggests
no mitigation actions for Fenoxycarb at this time.

Attachment 1.

Cases from the Incident Data System (IDS) for Fenoxycarb

Summary: There are 17 incident reports highlighted below. The last case
that was reported to the IDS was in 1998. The cases below provide a
sense of symptoms and circumstances where exposures were reported to
IDS. While IDS did not confirm life-threatening symptoms in these
reports from indoor and outdoor incidents, there were prevention
opportunities, as mention of an allergic reaction suggests a possible
situation that could progress to a life-threatening situation in persons
with pre-existing disease or a history of allergic reactions.

Incident#994-1

	A pesticide incident occurred in 1994, when the product was applied on
carpet in a bank.  Eighteen workers reported breathing problems, nausea,
headache, and sore throat.  The workers were treated by a physician.  No
further information on the disposition of the case was reported.

Incident#3640-1

	A pesticide incident occurred in 1996, when a pest control operator was
sprayed in the face with the product when a hose burst.  The operator
immediately turned off the pressure and little was released.  He rinsed
himself off, including his eyes, and used an absorbent material to clean
up the spill.  Specific symptoms were not mentioned.  No further
information on the disposition of the case was reported.

Incident#4697-15

	Lawsuit.

Incident#4697-70

	Lawsuit.

Incident#5895-42

	A pesticide incident occurred in 1995, when an individual was exposed
to the product while spreading a machine and the wind deposited some of
it into his ear.  The man reported ear pain and a swollen ear.  No
further information on the disposition of the case was reported.

Incident#5895-43

	A pesticide incident occurred in 1996, when a pregnant woman was
exposed to the product when a room was treated with it.  The woman
reported pulmonary irritation.  No further information on the
disposition of the case was reported.

Incident#5895-289

	A pesticide incident occurred in 1993, when an individual, who wore
gloves, was exposed while the product was applied around the house.  The
individual reported an allergic reaction including itching, blistering.
No further information on the disposition of the case reported.

Incident#5895-292

	A pesticide incident occurred in 1996, when a man’s daughter was
exposed to the product after the lawn was treated with it.  She reported
a rash on her entire body area, swollen eyes, forehead and feet and a
fever.  No further information on the disposition of the case was
reported.

Incident#5895-297

	A pesticide incident occurred in 1994, when an individual was exposed
to the product while spreading it.  The individual reported vomiting,
burning eyes, tremors, and diaphoresis.  No further information on the
disposition of the case was reported.

Incident#5895-527

	A pesticide incident occurred in 1993, when an individual was exposed
to the product after it was applied in their home.  The individual
reported a rash on their body.  No further information on the
disposition of the case was reported.

Incident#5895-529

	A pesticide incident occurred in 1995, when an individual was exposed
to the product after it was used in a home.  The individual reported
malaise.  No further information on the disposition of the case was
reported.

Incident#5895-531

	A pesticide incident occurred in 1996, when an individual was exposed
to the product when an occupied building was treated with it.  The
individual reported respiratory difficulty and a skin rash.  No further
information on the disposition of the case was reported.

Incident#5895-532

	A pesticide incident occurred in 1994, when an individual was exposed
to the product after it was used in the hospital.  The individual
reported headaches, sore throats, facial numbness, and nausea.  No
further information on the disposition of the case was reported.

Incident#5895-533

	A pesticide incident occurred in 1995, when an individual was exposed
to the product after their house was treated with it.  The individual
reported respiratory arrest (wheezing/heaving), and chest tightness.  No
further information on the disposition of the case was reported.

Incident#5895-534

	A pesticide incident occurred in 1992, when the product was applied at
a bank.  The individual reported emotional distress and chest tightness.
 No further information on the disposition of the case was reported.

Incident#5895-574

	A pesticide incident occurred in 1995, when a woman and her husband
were exposed after spraying the product in a house.  They reported
nausea, vomiting, severe headache, and tingling sensations in their
hands and feet.  No further information on the disposition of the case
was reported.

Incident#7235-1

	A pesticide incident occurred in 1998, when an individual applied the
product to 28 acres of an airstrip.  The individual reported difficulty
breathing, runny nose, and coughing.  No further information on the
disposition of the case was reported.

Attachment 2.

Table Description

The following is a general description of the table components that
compares the pesticide of interest with the composite average of all
pesticides. The table produces ratios in several health and exposure
measurements.

Table 1 General Explanation of Comparison of the Pesticide of Interest
with the Composite Average of all Pesticides.

	Severity of Outcome

(Outcome determined)	Total

Exposed	Health Care

Provided

Denominator numbers	25,549	68,005	18,084

Measures	SYM	MOD	MAJ	HCF	HOSP	ICU

Numerator numbers	578	83	9	18,084	302	219

Pesticide “X” percents	2.26%	0.32%	0.03%	26.59%	1.67%	1.21%

All Pesticides percents	21.72%	1.42%	0.12%	15.68%	4.34%	1.75%

Ratio of  “X”

to average of all pesticides	0.10(S)

P =0.00	0.23 (S)

P = 0.00	0.25 (S)

P = 0.01	1.69 (S)

P = 0.00	0.38 (S)

P = 0.00	0.69

P =0.51

A) The firs row, or title row, divides the table in three sub-tables
“Severity of Outcome”, “Total Exposed”, and “Health Care
Provided”

B) The second row “Denominator numbers” presents the numbers
extracted from the PCC database for the pesticide of interest “X”
that will serve as denominators in the calculation of the percents, and
they are:

In the center column, total amount of individuals exposed to pesticide
“X” (n = 68,005) or “Total Exposed”. These are cases collected
by the Poison Control Center for the period of interest regardless of
outcome.

In the left column under “Severity of Outcome”, is the number of
cases followed, (n = 25,546). These cases have an outcome determined
“Outcome determined” and these cases may  or may not have symptoms.

At the right of the table, cases that visited a Health Care Facility (n
= 18084) “Health Care Provided”.

C) The third row “Measures” describes the clinical outcome and level
of care required for the exposed cases:

“SYM” are those cases that were symptomatic;

“MOD” cases are those that were classified with moderate symptoms;

“MAJ” cases were cases classified as major symptoms or fatal
outcome;

“HCF” are cases that went to a Health Care Facility;

“HOSP” are cases that went to a hospital; and

“ICU” are cases that went to an Intensive Care Unit.

D) The fourth row “Numerator numbers” is actually the number of
cases for pesticide “X” that presented the outcome describe in the
“Measures” row. The numbers in this row are inclusive. This is, a
case classified as “Major”, is first classified as
“Symptomatic”, and also classified as “Moderate”; so a
“Major” case will count on the three measurements. The same scenario
applies to the “Health Care Provided” section; a case classified as
“ICU” also counts as a case that went to a “HCF” and to a
“Hospital”. In addition, a case classified as “Hospital” will
count also in “HCF” but not on “ICU”

E) The fifth row “Pesticide “X” percents” gives the percentages
on each measure. These percentages are calculated by dividing the
numerator number by the denominator number (from each major section of
the Table 1) and multiplying by 100. For example, to calculate SYM, MOD,
and MAJ, the numbers 578, 83 and 9 are divided by 25,549 on the first
row, producing the respective percents 2.26%, 0.32%, and 0.03%.  In a
similar fashion 18,084 is divided by 68,005 for the percentage of cases
seen in a HCF of 26.59%; and for the last section of the fifth row, 302
and 219 are divided by 18,084 to find the percentages, 1.67% and 1.21%,
of cases that went to a “Hospital” and “ICU”.

F) The sixth row “All Pesticides Percents” are percentages that were
previously calculated using all pesticide cases available in the PCC
database with the exception of cases involving exposures to multiple
products, cases with unrelated medical outcome, and cases where the
exposure was intentional. These exclusions make the comparison more
meaningful for US EPA regulatory program purposes. The percentages serve
as the baseline for the comparison with a single pesticide or a group.
These percentages are a unique characteristic for the “class” and
“period” of the data assembled in the table, and are completely
independent of the previously calculated values for pesticide “X”.

	G) The last row “Ratio of “X” to average of all pesticides” is
obtained by dividing the percentages of the “X” compound by the
“all pesticides” percentages, to obtain a dimensionless number or
ratio. This ratio provides an idea of the relative frequency of the
compound “X”. For example, a ratio of 1 (one) indicates that the
percentages are the same for the compound “X” and the composite of
all pesticides; a ratio, say of 2 (two), indicates that the chemical
under study produces twice the effect; and a ratio of 0.5 indicates that
the compound has half of the activity of the composite average. These
ratios provide a quick overview of the relative toxicity of the
chemical.

H) Also, the “p” value that results from a Likelihood ratio test is
entered in the ratio cell and when significant (p < 0.05) then an (S) is
entered next to the ratio to mark statistical significance. A cell
marked with (S) means that the percentages that produce the ratios are
“statistically” different and not due to chance. The percentage of
pesticide “X” could be higher or lower than the percentage produce
by the composite as indicated by the ratio. However, when mark by an (S)
the difference is significant. For example, a ratio = 1.6 (S) means the
effect produced by the compound is higher that the effect produced by
the composite and statistically different; a ratio = 0.7 (S) signifies
that pesticide “X” has a lower
e晦捥⁴桴湡琠敨挠浯潰楳整愠摮椠⁳瑳瑡獩楴慣汬⁹
楤晦牥湥⹴传桴瑯敨⁲慨摮慲楴‽⸱ⰲ眠瑩
潮⠠⥓敭湡⁳桴瑡琠敨瀠牥散瑮条ⱥ愠瑬潨杵楨
桧牥獩渠瑯猠慴楴瑳捩污祬搠晩敦敲瑮映潲桴潣
灭獯瑩⹥̍഍ഄ̍഍ഄ഍഍഍഍഍഍഍഍

഍

഍഍഍

഍

഍഍഍഍ഁ഍


[Federal Register Volume 78, Number 241 (Monday, December 16, 2013)]
[Notices]
[Page 76141]
[FR Doc No: 2013-29812]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

Combined Notice of Filings 1

    Take notice that the Commission received the following electric
rate filings:

    Docket Numbers: ER11-4027-003; ER11-4028-003.
    Applicants: James River Genco, LLC, Portsmouth Genco, LLC.
    Description: Notice of Non-Material Change in Status of James River
Genco, LLC, et. al.
    Filed Date: 12/5/13.
    Accession Number: 20131205-5177.
    Comments Due: 5 p.m. ET 12/26/13.

    Docket Numbers: ER14-318-001.
    Applicants: The Connecticut Light and Power Company.
    Description: LCRA with CMEEC Amended to be effective 1/1/2014.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5087.
    Comments Due: 5 p.m. ET 12/27/13.

    Docket Numbers: ER14-319-001.
    Applicants: Public Service Company of New Hampshire.
    Description: Localized Cost Responsibility Agreement with CTMEEC
Amended to be effective 1/1/2014.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5119.
    Comments Due: 5 p.m. ET 12/27/13.

    Docket Numbers: ER14-320-001.
    Applicants: Western Massachusetts Electric Company.
    Description: Localized Cost Responsibility Agreement with CTMEEC
Amended to be effective 1/1/2014.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5112.
    Comments Due: 5 p.m. ET 12/27/13.

    Docket Numbers: ER14-538-000.
    Applicants: Ameren Illinois Company.
    Description: Sectionalizing Switch Replacement Letter Agreement
with NEC to be effective 12/5/2013.
    Filed Date: 12/5/13.
    Accession Number: 20131205-5146.
    Comments Due: 5 p.m. ET 12/26/13.

    Docket Numbers: ER14-539-000.
    Applicants: Arizona Public Service Company.
    Description: Cancellation--Service Agreement No. 327 between APS
and the City of Azusa to be effective 12/31/2013.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5075.
    Comments Due: 5 p.m. ET 12/27/13.

    Docket Numbers: ER14-540-000.
    Applicants: Arizona Public Service Company.
    Description: APS Service Agreement No. 329--Azusa Simultaneous
Exchange to be effective 2/5/2014.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5078.
    Comments Due: 5 p.m. ET 12/27/13

    Docket Numbers: ER14-541-000.
    Applicants: Public Service Company of New Mexico.
    Description: Order No. 784 Compliance Filing to be effective 11/27/
2013.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5099.
    Comments Due: 5 p.m. ET 12/27/13.

    Docket Numbers: ER14-542-000.
    Applicants: Midcontinent Independent System Operator, Wolverine
Power Supply Cooperative, Inc.
    Description: 12-06-2013 SA 1316 Wolverine Grand Traverse IFA to be
effective 11/8/2013.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5120.
    Comments Due: 5 p.m. ET 12/27/13.

    Docket Numbers: ER14-543-000.
    Applicants: Niagara Mohawk Power Corporation, New York Independent
System Operator, Inc.
    Description: Amendment of Niagara Mohawk's Wholesale TSC in the
NYISO OATT to be effective 7/1/2013.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5130.
    Comments Due: 5 p.m. ET 12/27/13.

    Take notice that the Commission received the following electric
securities filings:

    Docket Numbers: ES14-13-000.
    Applicants: KCP&L Greater Missouri Operations Company.
    Description: Application for Authorization of Issuance of Short-
Term Debt Securities Under Section 204 of the Federal Power Act of
KCP&L Greater Missouri Operations Company.
    Filed Date: 12/6/13.
    Accession Number: 20131206-5033.
    Comments Due: 5 p.m. ET 12/27/13.

    The filings are accessible in the Commission's eLibrary system by
clicking on the links or querying the docket number.
    Any person desiring to intervene or protest in any of the above
proceedings must file in accordance with Rules 211 and 214 of the
Commission's Regulations (18 CFR 385.211 and 385.214) on or before 5:00
p.m. Eastern time on the specified comment date. Protests may be
considered, but intervention is necessary to become a party to the
proceeding.
    eFiling is encouraged. More detailed information relating to filing
requirements, interventions, protests, service, and qualifying
facilities filings can be found at: http://www.ferc.gov/docs-filing/efiling/filing-req.pdf. For other information, call<PHONE_NUMBER>
(toll free). For TTY, call<PHONE_NUMBER>.

    Dated: December 6, 2013.
Nathaniel J. Davis, Sr.,
Deputy Secretary.
[FR Doc. 2013-29812 Filed 12-13-13; 8:45 am]
BILLING CODE 6717-01-P


[Federal Register: December 12, 2008 (Volume 73, Number 240)]
[Notices]
[Page 75794-75803]
[DOCID:fr12de08-127]

-----------------------------------------------------------------------

DEPARTMENT OF TRANSPORTATION

Federal Motor Carrier Safety Administration

[Docket ID FMCSA-2008-0341]

Qualification of Drivers; Exemption Applications; Diabetes

AGENCY: Federal Motor Carrier Safety Administration (FMCSA).

ACTION: Notice of applications for exemptions from the diabetes
standard; request for comments.

-----------------------------------------------------------------------

SUMMARY: FMCSA announces receipt of applications from 84 individuals
for exemptions from the prohibition against persons with insulin-
treated diabetes mellitus (ITDM) operating commercial motor vehicles
(CMVs) in interstate commerce. If granted, the exemptions would enable
these individuals with ITDM to operate commercial motor vehicles in
interstate commerce.

DATES: Comments must be received on or before January 12, 2009.

ADDRESSES: You may submit comments bearing the Federal Docket
Management System (FDMS) Docket ID FMCSA-2007-0341 using any of the
following methods:
     Federal eRulemaking Portal: Go to http://
www.regulations.gov. Follow the on-line instructions for submitting
comments.
     Mail: Docket Management Facility; U.S. Department of
Transportation, 1200 New Jersey Avenue, SE., West Building Ground
Floor, Room W12-140, Washington, DC 20590-0001.
     Hand Delivery: West Building Ground Floor, Room W12-140,
1200 New Jersey Avenue, SE., Washington, DC, between 9 a.m. and 5 p.m.,
Monday through Friday, except Federal holidays.
     Fax: 1-202-493-2251.
    Each submission must include the Agency name and the docket ID for
this Notice. Note that DOT posts all comments received without change
to http://www.regulations.gov, including any personal information
included in a comment. Please see the Privacy Act heading below.
    Docket: For access to the docket to read background documents or
comments, go to http://www.regulations.gov at any time or Room W12-140
on the ground level of the West Building, 1200 New Jersey Avenue, SE.,
Washington, DC, between 9 a.m. and 5 p.m., Monday through Friday,
except Federal holidays. The FDMS is available 24 hours each day, 365
days each year. If you want acknowledgment that we received your
comments, please include a self-addressed, stamped envelope or postcard
or print the acknowledgement page that appears after submitting
comments on-line.
    Privacy Act: Anyone may search the electronic form of all comments
received into any of our dockets by the name of the individual
submitting the comment (or of the person signing the comment, if
submitted on behalf of an association, business, labor union, etc.).
You may review the DOT's complete Privacy Act Statement in the Federal
Register published on April 11, 2000 (65 FR 19476). This information is
also available at http://Docketinfo.dot.gov.

FOR FURTHER INFORMATION CONTACT: Dr. Mary D. Gunnels, Director, Medical
Programs,<PHONE_NUMBER><EMAIL_ADDRESS>FMCSA, Department of
Transportation, 1200 New Jersey Avenue, SE., Room W64-224, Washington,
DC 20590-0001. Office hours are from 8:30 a.m. to 5 p.m., Monday
through Friday, except Federal holidays.

SUPPLEMENTARY INFORMATION:

Background

    Under 49 U.S.C. 31136(e) and 31315, FMCSA may grant an exemption
for a 2-year period if it finds ``such exemption would likely achieve a
level of safety that is equivalent to, or greater than, the level that
would be achieved absent such exemption.'' The statutes also allow the
Agency to renew exemptions at the end of the 2-year period. The 84
individuals listed in this notice have recently requested an exemption
from the diabetes prohibition in 49 CFR 391.41(b) (3), which applies to
drivers of CMVs in interstate commerce. Accordingly, the Agency will
evaluate the qualifications of each applicant to determine whether
granting the exemption will achieve the required level of safety
mandated by the statutes.

Qualifications of Applicants

Edwin K. Anderson

    Mr. Anderson, age 57, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another

person, or resulting in impaired cognitive function that occurred
without warning in the past 5 years; understands diabetes management
and monitoring; and has stable control of his diabetes using insulin,
and is able to drive a CMV safely. Mr. Anderson meets the requirements
of the vision standard at 49 CFR 391.41(b)(10). His optometrist
examined him in 2008 and certified that he does not have diabetic
retinopathy. He holds a Class A Commercial Driver's License (CDL) from
Wisconsin.

Robert S. Althouse

    Mr. Althouse, 53, has had ITDM since 2001. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Althouse meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class C operator's license from
Pennsylvania.

James G. Arnoldussen, Sr.

    Mr. Arnoldussen, 49, has had ITDM since 1978. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Arnoldussen meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class A CDL from
Wisconsin.

William B. Bailor

    Mr. Bailor, 59, has had ITDM since 1977. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Bailor meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class D operator's
license from New York.

Kenneth E. Benoit

    Mr. Benoit, 66, has had ITDM since 2005. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Benoit meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Connecticut.

Thomas S. Benson

    Mr. Benson, 32, has had ITDM since 2005. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Benson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from North Carolina.

Dennis A. Boelens

    Mr. Boelens, 56, has had ITDM since 1994. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Boelens meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class B CDL from Illinois.

Melvin J. Boney

    Mr. Boney, 58, has had ITDM since 2006. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Boney meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Virginia.

Christopher D. Bostic

    Mr. Bostic, 23, has had ITDM since 2001. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Bostic meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class D chauffeur's license from
Louisiana.

Walter R. Braxton

    Mr. Braxton, 50, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Braxton meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Virginia.

Gordon M. Caldwell

    Mr. Caldwell, 47, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss

of consciousness, requiring the assistance of another person, or
resulting in impaired cognitive function that occurred without warning
in the past 5 years; understands diabetes management and monitoring;
and has stable control of his diabetes using insulin, and is able to
drive a CMV safely. Mr. Caldwell meets the requirements of the vision
standard at 49 CFR 391.41(b)(10). His optometrist examined him in 2008
and certified that he does not have diabetic retinopathy. He holds a
CDL from Washington.

Jake C. Cogswell

    Mr. Cogswell, 25, has had ITDM since 1992. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Cogswell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class D operator's license from
Minnesota.

Eric W. Crawford

    Mr. Crawford, 26, has had ITDM since 2004. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Crawford meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Texas.

Merle N. Cromwell

    Mr. Cromwell, 66, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Cromwell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from Illinois.

Trenn A. Davis

    Mr. Davis, 38, has had ITDM since 1980. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Davis meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class A CDL from
Kansas.

Bobby J. Davison

    Mr. Davison, 35, has had ITDM since 1998. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Davison meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class B CDL from Louisiana.

Donald J. DeBaets

    Mr. DeBaets, 69, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. DeBaets meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Wisconsin.

Anthony. Espinosa

    Mr. Espinosa, 37, has had ITDM since 2005. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Espinosa meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Missouri.

Gregory W. Eylar

    Mr. Eylar, 52, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Eylar meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Washington.

Stephen R. Ferrario

    Mr. Ferrario, 42, has had ITDM since 1994. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Ferrario meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from California.

Fred L. Frisch

    Mr. Frisch, 43, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the

past 5 years; understands diabetes management and monitoring; and has
stable control of his diabetes using insulin, and is able to drive a
CMV safely. Mr. Frisch meets the requirements of the vision standard at
49 CFR 391.41(b)(10). His ophthalmologist examined him in 2008 and
certified that he does have stable non-proliferative diabetic
retinopathy. He holds a Class A CDL from Ohio.

Raymond J. Ford

    Mr. Ford, 54, has had ITDM since 1988. His endocrinologist examined
him in 2008 and certified that he has had no hypoglycemic reactions
resulting in loss of consciousness, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning in the past 5 years; understands diabetes management
and monitoring; and has stable control of his diabetes using insulin,
and is able to drive a CMV safely. Mr. Ford meets the requirements of
the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist
examined him in 2008 and certified that he has stable non-proliferative
diabetic retinopathy. He holds a Class C operator's license from
California.

Kevin J. Fries

    Mr. Fries, 48, has had ITDM since 1994. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Fries meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class D operator's license from
Montana.

Douglas E. Fuller

    Mr. Fuller, 42, has had ITDM since 2004. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Fuller meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from North Carolina.

Daniel D. Greenwell

    Mr. Greenwell, 43, has had ITDM since 1989. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Greenwell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does have
stable non-proliferative diabetic retinopathy. He holds a Class A CDL
from New York.

William G. Hansen

    Mr. Hansen, 56, has had ITDM since 2006. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hansen meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does have
stable non-proliferative diabetic retinopathy. He holds a Class A CDL
from Oregon.

George H. Hayes, Jr.

    Mr. Hayes, 54, has had ITDM since 1995. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hayes meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Virginia.

Danny E. Hillier

    Mr. Hillier, 46, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hillier meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from North Dakota.

John H. Hilliges

    Mr. Hilliges, 53, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hilliges meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Nebraska.

Thomas Hogan

    Mr. Hogan, 77, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Hogan meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class A CDL from
Ohio.

Harvey J. Hollins

    Mr. Hollins, 61, has had ITDM since 2003. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or

resulting in impaired cognitive function that occurred without warning
in the past 5 years; understands diabetes management and monitoring;
and has stable control of his diabetes using insulin, and is able to
drive a CMV safely. Mr. Hollins meets the requirements of the vision
standard at 49 CFR 391.41(b)(10). His ophthalmologist examined him in
2008 and certified that he does not have diabetic retinopathy. He holds
a Class A CDL from Nevada.

John Horta

    Mr. Horta, 45, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Horta meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does have
stable non-proliferative diabetic retinopathy. He holds a Class D
operator's license from Arizona.

Paris J. Howell

    Mr. Howell, 43, has had ITDM since 2006. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Howell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class D operator's license from
Tennessee.

Eric J. Huffman

    Mr. Huffman, 29, has had ITDM since 1990. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Huffman meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from South Dakota.

Tyson C. Johnson

    Mr. Johnson, 25, has had ITDM since 1993. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Johnson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class C operator's
license from Pennsylvania.

Ken M. Jorgenson

    Mr. Jorgenson, 56, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Jorgenson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Minnesota.

Barry J. Kelley

    Mr. Kelley, 35, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Kelley meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class C operator's license from
Maryland.

John H. Kingsley

    Mr. Kingsley, 44, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Kingsley meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Virginia.

Gary J. Klostermann

    Mr. Klostermann, 52, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Klostermann meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Iowa.

Steven F. Kohalmi

    Mr. Kohalmi, 52, has had ITDM since 2006. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Kohalmi meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class C operator's license from
Pennsylvania.

Peter D. Krenz

    Mr. Krenz, 55, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no

hypoglycemic reactions resulting in loss of consciousness, requiring
the assistance of another person, or resulting in impaired cognitive
function that occurred without warning in the past 5 years; understands
diabetes management and monitoring; and has stable control of his
diabetes using insulin, and is able to drive a CMV safely. Mr. Krenz
meets the requirements of the vision standard at 49 CFR 391.41(b)(10).
His optometrist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class C operator's license from
Oregon.

Robert J. Lampman

    Mr. Lampman, 66, has had ITDM since 2002. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Lampman meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class C CDL from Michigan.

Jason C. Lang

    Mr. Lang, 33, has had ITDM since 2008. His endocrinologist examined
him in 2008 and certified that he has had no hypoglycemic reactions
resulting in loss of consciousness, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning in the past 5 years; understands diabetes management
and monitoring; and has stable control of his diabetes using insulin,
and is able to drive a CMV safely. Mr. Lang meets the requirements of
the vision standard at 49 CFR 391.41(b)(10). His optometrist examined
him in 2008 and certified that he does not have diabetic retinopathy.
He holds a Class A CDL from Vermont.

Kevin J. Lavoie

    Mr. Lavoie, 41, has had ITDM since 1988. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Lavoie meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Oregon.

Dennis M. Lester

    Mr. Lester, 47, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Lester meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class C operator's license from North
Carolina.

Dario Lopez

    Mr. Lopez, 27, has had ITDM since 1996. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Lopez meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class D operator's license from
Illinois.

Jerald L. Marquardt

    Mr. Marquardt, 48, has had ITDM since 1989. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Marquardt meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does have
stable non-proliferative diabetic retinopathy. He holds a Class B CDL
from Illinois.

Robert H. McCann, III.

    Mr. McCann, 51, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. McCann meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class B CDL from
Maryland.

Lewis S. Needles

    Mr. Needles, 54, has had ITDM since 2006. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Needles meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class C CDL from New Jersey.

Derald W. Newton

    Mr. Newton, 55, has had ITDM since 1973. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Newton meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class D operator's
license from New Mexico.

Galen L. Nightingale

    Mr. Nightingale, 65, has had ITDM since 2005. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Nightingale meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class A CDL from
Kansas.

Chris C. Northway

    Mr. Northway, 47, has had ITDM since 2000. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Northway meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Wisconsin.

John D. Owens

    Mr. Owens, 59, has had ITDM since 2005. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Owens meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Indiana.

Theodore S. Pankiewicz

    Mr. Pankiewicz, 32, has had ITDM since 1978. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Pankiewicz meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
proliferative diabetic retinopathy. He holds a Class C operator's
license from Pennsylvania.

Jody A. Peckels

    Mr. Peckels, 48, has had ITDM since 2002. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Peckels meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Oregon.

James H. Pfeiffer

    Mr. Pfeiffer, 35, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Pfeiffer meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Illinois.

Marc R. Pream

    Mr. Pream, 61, has had ITDM since 2005. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Pream meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class D operator's license from
Minnesota.

Travis W. Proctor

    Mr. Proctor, 31, has had ITDM since 1995. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Proctor meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class C operator's license from
Georgia.

William B. Racobs

    Mr. Racobs, 62, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Racobs meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Iowa.

Remson H. Rawson

    Mr. Rawson, 54, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Rawson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy.

He holds a Class A CDL from North Carolina.

Ann M. Reinke

    Ms. Reinke, 53, has had ITDM since 2008. Her endocrinologist
examined her in 2008 and certified that she has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of her diabetes using
insulin, and is able to drive a CMV safely. Ms. Reinke meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). Her
optometrist examined her in 2008 and certified that she does not have
diabetic retinopathy. She holds a Class B CDL from Wisconsin.

Frank W. Reynolds

    Mr. Reynolds, 37, has had ITDM since 2006. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Reynolds meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class C operator's license from North
Carolina.

Vincente L. Rodriquez

    Mr. Rodriquez, 24, has had ITDM since 1997. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Rodriquez meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class B CDL from New Mexico.

Bradley C. Roen

    Mr. Roen, 47, has had ITDM since 2007. His endocrinologist examined
him in 2008 and certified that he has had no hypoglycemic reactions
resulting in loss of consciousness, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning in the past 5 years; understands diabetes management
and monitoring; and has stable control of his diabetes using insulin,
and is able to drive a CMV safely. Mr. Roen meets the requirements of
the vision standard at 49 CFR 391.41(b)(10). His optometrist examined
him in 2008 and certified that he does not have diabetic retinopathy.
He holds a Class B CDL from Wisconsin.

Thomas C. Routon

    Mr. Routon, 38, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Routon meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
proliferative diabetic retinopathy. He holds a Class D operator's
license from Minnesota.

Tyler A. Russell

    Mr. Russell, 25, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Russell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Massachusetts.

Randy L. Schroeder

    Mr. Schroeder, 51, has had ITDM since 2003. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Schroeder meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from New York.

Michael W. Sharp

    Mr. Sharp, 38, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Sharp meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Missouri.

Nathaniel B. Shaw

    Mr. Shaw, 23, has had ITDM since 2003. His endocrinologist examined
him in 2008 and certified that he has had no hypoglycemic reactions
resulting in loss of consciousness, requiring the assistance of another
person, or resulting in impaired cognitive function that occurred
without warning in the past 5 years; understands diabetes management
and monitoring; and has stable control of his diabetes using insulin,
and is able to drive a CMV safely. Mr. Shaw meets the requirements of
the vision standard at 49 CFR 391.41(b)(10). His ophthalmologist
examined him in 2008 and certified that he does not have diabetic
retinopathy. He holds a Class A CDL from Illinois.

Sean L. Shidell

    Mr. Shidell, 38, has had ITDM since 2007. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Shidell meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that

he does not have diabetic retinopathy. He holds a Class A CDL from
Florida.

Wendell R. Shults

    Mr. Shults, 43, has had ITDM since 1991. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Shults meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class C operator's license from Texas.

Joseph B. Simon

    Mr. Simon, 37, has had ITDM since 1978. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Simon meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
non-proliferative diabetic retinopathy. He holds a Class A CDL from New
York.

David E. Steinke

    Mr. Steinke, 64, has had ITDM since 2002. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Steinke meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Wisconsin.

Floyd T. Stokes

    Mr. Stokes, 56, has had ITDM since 2006. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Stokes meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class A CDL from Florida.

Gary E. Stone

    Mr. Stone, 55, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Stone meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Pennsylvania.

Timothy D. Stone

    Mr. Stone, 26, has had ITDM since 2004. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Stone meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he does not
have diabetic retinopathy. He holds a Class D operator's license from
Arizona.

Anthony A. Thomas

    Mr. Thomas, 38, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Thomas meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Kentucky.

William J. Thomas

    Mr. Thomas, 60, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Thomas meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from North Carolina.

Kaleo B. Tokunaga

    Mr. Tokunaga, 40, has had ITDM since 2008. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Tokunaga meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class A CDL from Hawaii.

John R. Turcotte

    Mr. Turcotte, 61, has had ITDM since 2001. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Turcotte meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that

he does not have diabetic retinopathy. He holds a Class A CDL from
Maine.

Danny J. Watson

    Mr. Watson, 45, has had ITDM since 1978. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Watson meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class D operator's license from
Kentucky.

Eric W. Williams

    Mr. Williams, 52, has had ITDM since 2005. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Williams meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
optometrist examined him in 2008 and certified that he does not have
diabetic retinopathy. He holds a Class C operator's license from
Maryland.

Russell A. Williams

    Mr. Williams, 62, has had ITDM since 2005. His endocrinologist
examined him in 2008 and certified that he has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of his diabetes using
insulin, and is able to drive a CMV safely. Mr. Williams meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). His
ophthalmologist examined him in 2008 and certified that he has stable
proliferative diabetic retinopathy. He holds a Class A CDL from
Wisconsin.

Kimberly A. Woehrman

    Ms. Woehrman, 44, has had ITDM since 2001. Her endocrinologist
examined her in 2008 and certified that she has had no hypoglycemic
reactions resulting in loss of consciousness, requiring the assistance
of another person, or resulting in impaired cognitive function that
occurred without warning in the past 5 years; understands diabetes
management and monitoring; and has stable control of her diabetes using
insulin, and is able to drive a CMV safely. Ms. Woehrman meets the
requirements of the vision standard at 49 CFR 391.41(b)(10). Her
ophthalmologist examined her in 2008 and certified that she does not
have diabetic retinopathy. She holds a Class A CDL from Kansas.

Request for Comments

    In accordance with 49 U.S.C. 31136(e) and 31315, FMCSA requests
public comment from all interested persons on the exemption petitions
described in this notice. We will consider all comments received before
the close of business on the closing date indicated in the date section
of the Notice.
    FMCSA notes that Section 4129 of the Safe, Accountable, Flexible
and Efficient Transportation Equity Act: A Legacy for Users (SAFETEA-
LU) requires the Secretary to revise its diabetes exemption program
established on September 3, 2003 (68 FR 52441).\1\ The revision must
provide for individual assessment of drivers with diabetes mellitus,
and be consistent with the criteria described in section 4018 of the
Transportation Equity Act for the 21st Century (49 U.S.C. 31305).
---------------------------------------------------------------------------

    \1\ Section 4129(a) refers to the 2003 Notice as a ``final
rule.'' However, the 2003 Notice did not issue a ``final rule'' but
did establish the procedures and standards for issuing exemptions
for drivers with ITDM.
---------------------------------------------------------------------------

    Section 4129 requires: (1) the elimination of the requirement for
three years of experience operating CMVs while being treated with
insulin; and (2) the establishment of a specified minimum period of
insulin use to demonstrate stable control of diabetes before being
allowed to operate a CMV.
    In response to section 4129, FMCSA made immediate revisions to the
diabetes exemption program established by the September 3, 2003 Notice.
FMCSA discontinued use of the 3-year driving experience and fulfilled
the requirements of section 4129 while continuing to ensure that
operation of CMVs by drivers with ITDM will achieve the requisite level
of safety required of all exemptions granted under 49 USC. 31136 (e).
    Section 4129(d) also directed FMCSA to ensure that drivers of CMVs
with ITDM are not held to a higher standard than other drivers, with
the exception of limited operating, monitoring and medical requirements
that are deemed medically necessary. FMCSA concluded that all of the
operating, monitoring and medical requirements set out in the September
3, 2003 Notice, except as modified, were in compliance with section
4129(d). Therefore, all of the requirements set out in the September 3,
2003 Notice, except as modified by the Notice in the Federal Register
on November 8, 2005 (70 FR 67777), remain in effect.

    Issued on: December 5, 2008.
Larry W. Minor,
Associate Administrator for Policy and Program Development.
[FR Doc. E8-29418 Filed 12-11-08; 8:45 am]

BILLING CODE 4910-EX-P


[Federal Register: May 21, 2008 (Volume 73, Number 99)]
[Notices]
[Page 29500]
[DOCID:fr21my08-45]

-----------------------------------------------------------------------

DEPARTMENT OF ENERGY

Federal Energy Regulatory Commission

[Project No. 12623-001]

Black River Felts Mills LLC; Notice of Intent To File License
Application, Filing of Pre-Application Document, and Approving Use of
the Traditional Licensing Process

May 14, 2008.
    a. Type of Filing: Notice of Intent to File License Application and
Request to Use the Traditional Licensing Process.
    b. Project No.: 12623-001.
    c. Dated Filed: April 2, 2008.
    d. Submitted By: Black River Felts Mills LLC.
    e. Name of Project: Great Bend Hydroelectric Project.
    f. Location: On the Black River, in Jefferson County, New York. No
federal lands would be occupied by the project works.
    g. Filed Pursuant to: 18 CFR 5.3 of the Commission's regulations.
    h. Potential Applicant Contact: Keith Silliman, Black River Felts
Mills, LLC, c/o Brookfield Power U.S. Holdings America Co., 225
Greenway Parkway, Suite 201, Liverpool, NY 13088;<PHONE_NUMBER>; e-
<EMAIL_ADDRESS>    i. FERC Contact: John Costello at<PHONE_NUMBER>; or e-mail at
<EMAIL_ADDRESS>    j. Black River Felts Mills LLC filed its request to use the
Traditional Licensing Process on April 2, 2008. Black River Felts Mills
LLC provided public notice of its request on April 8, 2008. In a letter
dated May 13, 2008, the Director of the Office of Energy Projects
approved Black River Felts Mills LLC request to use the Traditional
Licensing Process.
    k. With this notice, we are initiating informal consultation with:
(a) The U.S. Fish and Wildlife Service under section 7 of the
Endangered Species Act and the joint agency regulations thereunder at
50 CFR, part 402; (b) NOAA Fisheries under section 305(b) of the
Magnuson-Stevens Fishery Conservation and Management Act and
implementing regulations at 50 CFR 600.920; and (c) the New York State
Historic Preservation Officer, as required by Section 106, National
Historical Preservation Act, and the implementing regulations of the
Advisory Council on Historic Preservation at 36 CFR 800.2.
    l. With this notice, we are designating Black River Felts Mills LLC
as the Commission's non-federal representative for carrying out
informal consultation, pursuant to section 7 of the Endangered Species
Act, section 305 of the Magnuson-Stevens Fishery Conservation and
Management Act, and section 106 of the National Historic Preservation
Act.
    m. Black River Felts Mills LLC filed a Pre-Application Document
(PAD; including a proposed process plan and schedule) with the
Commission, pursuant to 18 CFR 5.6 of the Commission's regulations.
    n. A copy of the PAD is available for review at the Commission in
the Public Reference Room or may be viewed on the Commission's Web site
(http://www.ferc.gov), using the ``eLibrary'' link. Enter the docket
number, excluding the last three digits in the docket number field to
access the document. For assistance, contact FERC Online Support at
<EMAIL_ADDRESS>or toll free at 1-866-208-3676, of for TTY,
(202) 502-8659. A copy is also available for inspection and
reproduction at the address in paragraph h.
    o. Register online at http://ferc.gov/esubscribenow.htm to be
notified via e-mail of new filing and issuances related to this or
other pending projects. For assistance, contact FERC Online Support.

Kimberly D. Bose,
Secretary.
 [FR Doc. E8-11334 Filed 5-20-08; 8:45 am]

BILLING CODE 6717-01-P